Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Benazepril (ATC N° C09AA07) in the Treatment of Persistent Renal Dysfunction in Pre-eclamptic Women
NCT01095939 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Benazepril (ATC N° C09AA07) in the Treatment of Persistent Renal Dysfunction in Pre-eclamptic Women
- Lead sponsor
- University Hospital, Geneva
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- March 31, 2018
- Enrollment
- 120 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
renal alteration